We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

98 hedge funds and large institutions have $419M invested in Enanta Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

189% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 9

100% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 23

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

24% more capital invested

Capital invested by funds: $339M → $419M (+$80M)

21% more funds holding

Funds holding: 81 → 98 (+17)

15% more call options, than puts

Call options by funds: $1.35M | Put options by funds: $1.17M

Holders
98
Holders Change
+17
Holders Change %
+20.99%
% of All Funds
2.82%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
26
Increased
46
Reduced
23
Closed
9
Calls
$1.35M
Puts
$1.17M
Net Calls
+$177K
Net Calls Change
-$223K

Top Buyers

1
CCM
Consonance Capital Management
New York
+$11.1M
2
EAM
Eagle Asset Management
Florida
+$10.4M
3
GT
Glenmede Trust
Pennsylvania
+$8.55M
4
BFA
BlackRock Fund Advisors
California
+$5.8M
5
SAM
Senzar Asset Management
New York
+$4.35M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.7M
2
HAMF
Hatteras Alternative Mutual Funds
North Carolina
-$2.36M
3
ICRM
Insight Capital Research & Management
California
-$1.85M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.22M
5
GPCM
Granite Point Capital Management
Massachusetts
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
51
STRS Ohio
Ohio
$732K +$15.3K +400 +2%
Two Sigma Investments
52
Two Sigma Investments
New York
$711K +$629K +16,499 New
Asset Management One
53
Asset Management One
Japan
$682K +$71K +1,862 +14%
NFA
54
Nationwide Fund Advisors
Ohio
$630K +$146K +3,815 +35%
TA
55
Teachers Advisors
New York
$609K +$316K +8,284 +141%
GC
56
Guggenheim Capital
Illinois
$562K +$484K +12,697 New
SIM
57
Spark Investment Management
New York
$559K +$496K +13,000 New
Jane Street
58
Jane Street
New York
$467K +$414K +10,851 New
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$396K +$351K +9,203 New
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
$379K +$132K +3,452 +64%
US Bancorp
61
US Bancorp
Minnesota
$366K +$324K +8,501 New
Swiss National Bank
62
Swiss National Bank
Switzerland
$362K +$99.2K +2,600 +45%
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$354K +$314K +8,222 New
AllianceBernstein
64
AllianceBernstein
Tennessee
$336K +$295K +7,724 +10,163%
Citadel Advisors
65
Citadel Advisors
Florida
$311K +$38.6K +1,011 +16%
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$300K +$140K +3,667 +111%
AIG
67
American International Group
New York
$291K +$163K +4,286 +173%
PNC Financial Services Group
68
PNC Financial Services Group
Pennsylvania
$290K -$10.5K -274 -4%
PPA
69
Parametric Portfolio Associates
Washington
$278K +$247K +6,462 New
Millennium Management
70
Millennium Management
New York
$233K +$207K +5,415 New
VOYA Investment Management
71
VOYA Investment Management
Georgia
$228K +$202K +5,290 New
Truist Financial
72
Truist Financial
North Carolina
$221K +$1.91K +50 +1%
BG
73
BlackRock Group
United Kingdom
$217K +$144K +3,767 +296%
ProShare Advisors
74
ProShare Advisors
Maryland
$217K +$192K +5,036 New
Goldman Sachs
75
Goldman Sachs
New York
$215K +$191K +4,999 New
1 2
3
4 5

ENTA Hedge Fund Activity: Q2 2014 in Review

98 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q2 2014, worth a combined $419M — up 24% from $339M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ENTA positions and 9 closed out — a net gain of 17 holders — while 46 added to existing stakes and 23 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $11.1M. The largest seller was Fidelity Investments, cutting an estimated $17.7M.

  • 98 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q2 2014, up from 81 in Q1 2014.
  • Funds reported $419M of Enanta Pharmaceuticals stock for Q2 2014, up 24% quarter-over-quarter.
  • 26 funds opened new Enanta Pharmaceuticals positions in Q2 2014 and 9 closed out, a net change of +17 holders.
  • The largest Enanta Pharmaceuticals buyer in Q2 2014 was Consonance Capital Management, an estimated $11.1M added.
  • The largest Enanta Pharmaceuticals seller in Q2 2014 was Fidelity Investments, an estimated $17.7M sold.

Based on aggregated 13F filings for Q2 2014.